全文获取类型
收费全文 | 2314篇 |
免费 | 175篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 80篇 |
妇产科学 | 30篇 |
基础医学 | 368篇 |
口腔科学 | 66篇 |
临床医学 | 207篇 |
内科学 | 381篇 |
皮肤病学 | 22篇 |
神经病学 | 230篇 |
特种医学 | 185篇 |
外科学 | 255篇 |
综合类 | 143篇 |
一般理论 | 2篇 |
预防医学 | 252篇 |
眼科学 | 29篇 |
药学 | 122篇 |
中国医学 | 4篇 |
肿瘤学 | 95篇 |
出版年
2021年 | 51篇 |
2020年 | 19篇 |
2019年 | 18篇 |
2018年 | 32篇 |
2017年 | 26篇 |
2016年 | 29篇 |
2015年 | 31篇 |
2014年 | 48篇 |
2013年 | 60篇 |
2012年 | 96篇 |
2011年 | 102篇 |
2010年 | 94篇 |
2009年 | 62篇 |
2008年 | 93篇 |
2007年 | 64篇 |
2006年 | 88篇 |
2005年 | 81篇 |
2004年 | 84篇 |
2003年 | 56篇 |
2002年 | 64篇 |
2001年 | 65篇 |
2000年 | 62篇 |
1999年 | 54篇 |
1998年 | 51篇 |
1997年 | 42篇 |
1996年 | 46篇 |
1995年 | 28篇 |
1994年 | 50篇 |
1993年 | 25篇 |
1992年 | 47篇 |
1991年 | 38篇 |
1990年 | 44篇 |
1989年 | 53篇 |
1988年 | 56篇 |
1987年 | 66篇 |
1986年 | 58篇 |
1985年 | 46篇 |
1984年 | 33篇 |
1983年 | 36篇 |
1982年 | 23篇 |
1981年 | 22篇 |
1980年 | 21篇 |
1979年 | 48篇 |
1978年 | 19篇 |
1976年 | 22篇 |
1974年 | 17篇 |
1973年 | 25篇 |
1972年 | 16篇 |
1969年 | 16篇 |
1966年 | 19篇 |
排序方式: 共有2493条查询结果,搜索用时 15 毫秒
41.
42.
阿魏酸钠对乙醇所致小鼠肝脏抗氧化功能改变的拮抗作用 总被引:19,自引:0,他引:19
研究了不同剂量乙醇对小鼠抗氧化和解毒功能的影响以及阿魏酸钠的拮抗作用。结果表明,大剂量乙醇(11.4g·kg-1ig)引起肝脏GSH-Px活性升高的同时,肝脏GSH-Re,SOD和GST活性降低,GSH耗竭,而血清GST升高;阿魏酸钠(100mg·kg-1ig,qd×10)预处理则明显拮抗大剂量乙醇所致的上述改变。表明阿魏酸钠对急性乙醇所致肝损害具有良好保护作用,其机理可能与提高GSH氧化还原酶功能、增加SOD活性和增强GSH结合反应有关。研究结果还提示,血清GST水平是反映乙醇性肝损害的灵敏指标。 相似文献
43.
Moore MR Hyde TB Hennessy TW Parks DJ Reasonover AL Harker-Jones M Gove J Bruden DL Rudolph K Parkinson A Butler JC Schuchat A 《The Journal of infectious diseases》2004,190(11):2031-2038
BACKGROUND: Streptococcus pneumoniae is a leading cause of invasive bacterial disease and pneumonia among children. Antimicrobial resistance among pneumococci has increased in recent years and complicates treatment. The introduction of heptavalent pneumococcal conjugate vaccine (PCV7) could reduce acquisition of antimicrobial-resistant pneumococci. METHODS: We obtained 1350 nasopharyngeal swabs for culture from 1275 children aged 3-59 months presenting at 3 clinics in Anchorage, Alaska, during the winters of 2000, 2001, and 2002, as PCV7 was being introduced into the routine immunization schedule. We recorded the frequency of use of antibiotics as well as the dates of doses of PCV7 for enrolled children. We used multivariate logistic regression modeling to identify independent risk factors for overall carriage of pneumococci and carriage of PCV7-type pneumococci, cotrimoxazole-nonsusceptible (COT-NS) pneumococci, or penicillin-nonsusceptible (PCN-NS) pneumococci. RESULTS: The proportion of children who were up-to-date for age, with respect to PCV7 vaccination, increased from 0% in 2000 to 55% in 2002. Carriage of PCV7-type pneumococci decreased by 43% (P<.0001). Risk of carriage of PCV7-type pneumococci was lower in 2002 than in 2000, independent of vaccination status, suggesting an indirect effect of vaccination. Carriage of COT-NS, but not PCN-NS, pneumococci also decreased (38%; P=.02), not only among vaccinated children but also among unvaccinated children without recent use of antibiotics. CONCLUSIONS: Introduction of PCV7 into the routine infant immunization schedule in a community with a high prevalence of antimicrobial-resistant pneumococci appears to reduce transmission of PCV7 vaccine serotypes and COT-NS pneumococci but has no impact on overall carriage of pneumococci or carriage of PCN-NS pneumococci. 相似文献
44.
Mudrakola Harsha V. Caples Sean M. Hyde Robert J. McBane II Robert D. Ahmad Sumera R. 《Journal of thrombosis and thrombolysis》2022,54(1):145-152
Journal of Thrombosis and Thrombolysis - The optimal management strategy for submassive or intermediate risk pulmonary embolism (IRPE)—anticoagulation alone versus anticoagulation plus... 相似文献
45.
Logical properties of angiotensin II receptors in the rat adenohypophysis were analyzed in cultured rat pituitary cells incubated with angiotensin II and known stimuli of pituitary hormone secretion. PRL release during incubation for 3 h with 3 nM angiotensin II was consistently increased by 68 +/- 5%, comparable with that elicited by TRH (63.1 +/- 4%). The ED50 of 0.5 nM for PRL release by angiotensin II was significantly lower than that of TRH (2.9 nM) in the same cell cultures. The antagonist analog [Sar1,Ala8]angiotensin II prevented the angiotensin-induced rise in PRL production but not that evoked by TRH, whereas dopamine and SRIF inhibited basal, angiotensin, and TRH-stimulated PRL release. Angiotensin II also caused a small increase in ACTH release but had no effect on the release of LH, TSH, and GH. Angiotensin II binding and PRL release were measured in partially purified lactotrophs prepared by elutriation, by which the initial cell suspension was separated into seven fractions. Most of the lactotrophs were present in the two fractions eluted at flow rates of 15.7 and 19.8 ml/min, as indicated by their immunoreactive PRL content. The 2.5- to 3.2-fold enrichment of lactotrophs was accompanied by a 2- to 3.5-fold increase in angiotensin II receptor concentration, with no change in binding affinity (Ka = 3.5 x 10(9) M-1). In the same fractions, angiotensin II-induced PRL release was similarly increased by 1.6- to 3.5-fold above basal, compared with values of less than 1 in the initial cell suspension and other fractions. The preferential location of angiotensin II receptors in the lactotroph-containing fractions and the close correlation between angiotensin II binding sites and stimulation of PRL release indicate the functional importance of the pituitary angiotensin II receptor sites. These findings also suggest that angiotensin II could contribute to the physiological regulation of PRL secretion. 相似文献
46.
47.
48.
49.
Carroll Sarah L. Clark D. Angus Hyde Luke W. Klump Kelly L. Burt S. Alexandra 《Behavior genetics》2021,51(5):580-591
Behavior Genetics - Trajectories of youth antisocial behavior (ASB) are characterized by both continuity and change. Twin studies have further indicated that genetic factors underlie continuity,... 相似文献
50.
K Ohi G Ursini M Li J H Shin T Ye Q Chen R Tao J E Kleinman T M Hyde R Hashimoto D R Weinberger 《Translational psychiatry》2015,5(4):e550
A genome-wide association study of cognitive deficits in patients with schizophrenia in Japan found association with a missense genetic variant (rs7157599, Asn8Ser) in the delta(4)-desaturase, sphingolipid 2 (DEGS2) gene. A replication analysis using Caucasian samples showed a directionally consistent trend for cognitive association of a proxy single-nucleotide polymorphism (SNP), rs3783332. Although the DEGS2 gene is expressed in human brain, it is unknown how DEGS2 expression varies during human life and whether it is affected by psychiatric disorders and genetic variants. To address these questions, we examined DEGS2 messenger RNA using next-generation sequencing in postmortem dorsolateral prefrontal cortical tissue from a total of 418 Caucasian samples including patients with schizophrenia, bipolar disorder and major depressive disorder. DEGS2 is expressed at very low levels prenatally and increases gradually from birth to adolescence and consistently expressed across adulthood. Rs3783332 genotype was significantly associated with the expression across all subjects (F3,348=10.79, P=1.12 × 10−3), particularly in control subjects (F1,87=13.14, P=4.86 × 10−4). Similar results were found with rs715799 genotype. The carriers of the risk-associated minor allele at both loci showed significantly lower expression compared with subjects homozygous for the non-risk major allele and this was a consistent finding across all diagnostic groups. DEGS2 expression showed no association with diagnostic status after correcting for multiple testing (P>0.05). Our findings demonstrate that a SNP showing genome-wide association study significant association with cognition in schizophrenia is also associated with regulation of DEGS2 expression, implicating a molecular mechanism for the clinical association. 相似文献